Value-based procurement of prostheses for total knee replacement

Cost-effectiveness evaluations concerning devices for total knee arthroplasty (TKA) have little impact on real-life management of these devices. This study explored how pharmacoeconomic models can inform the procurement of TKA devices to improve their value for money. Our study included three phases...

Full description

Bibliographic Details
Main Authors: Andrea Messori, Sabrina Trippoli
Format: Article
Language:English
Published: Open Medical Publishing 2018-02-01
Series:Orthopedic Reviews
Subjects:
Online Access:http://www.pagepress.org/journals/index.php/or/article/view/7488
id doaj-d6be96c1844d4ca68eb2a93fd060f503
record_format Article
spelling doaj-d6be96c1844d4ca68eb2a93fd060f5032021-05-02T21:16:24ZengOpen Medical PublishingOrthopedic Reviews2035-82372035-81642018-02-019410.4081/or.2017.74883881Value-based procurement of prostheses for total knee replacementAndrea Messori0Sabrina Trippoli1HTA Section, ESTAR Toscana, Regional Health Service, FirenzeHTA Section, ESTAR Toscana, Regional Health Service, FirenzeCost-effectiveness evaluations concerning devices for total knee arthroplasty (TKA) have little impact on real-life management of these devices. This study explored how pharmacoeconomic models can inform the procurement of TKA devices to improve their value for money. Our study included three phases: i) literature search for data of outcome, cost, and device type in TKA; ii) development of a Markov model predicting costs, QALYs, and net monetary benefit (NMB); iii) simulation of tenders aimed at value-based device procurement. Phases 1 and 2 were managed by selecting a single study as the source of data for our analysis. In Phase 3, each TKA device was associated with its values of NMB, and the tender scores were estimated. Finally, the ranking of each device in the simulated tender was determined. We identified a study published in 2016 as our source of data. Five devices were evaluated. For these devices, QALYs were 7.3952, 7.2939, 7.4952, 7.1919, 7.2930; NMB: £142,005, £140,653, £144,184, £138,040, £140,261; tender scores: 64.53, 42.53, 100, 0, 36.15, respectively. We showed that incorporating the principles of cost-effectiveness into the tendering process is feasible for TKA devices. This can maximize the value for money for these devices.http://www.pagepress.org/journals/index.php/or/article/view/7488knee arthroplastycost-effectivenessMarkov modelingnet monetary benefittendersprocurement
collection DOAJ
language English
format Article
sources DOAJ
author Andrea Messori
Sabrina Trippoli
spellingShingle Andrea Messori
Sabrina Trippoli
Value-based procurement of prostheses for total knee replacement
Orthopedic Reviews
knee arthroplasty
cost-effectiveness
Markov modeling
net monetary benefit
tenders
procurement
author_facet Andrea Messori
Sabrina Trippoli
author_sort Andrea Messori
title Value-based procurement of prostheses for total knee replacement
title_short Value-based procurement of prostheses for total knee replacement
title_full Value-based procurement of prostheses for total knee replacement
title_fullStr Value-based procurement of prostheses for total knee replacement
title_full_unstemmed Value-based procurement of prostheses for total knee replacement
title_sort value-based procurement of prostheses for total knee replacement
publisher Open Medical Publishing
series Orthopedic Reviews
issn 2035-8237
2035-8164
publishDate 2018-02-01
description Cost-effectiveness evaluations concerning devices for total knee arthroplasty (TKA) have little impact on real-life management of these devices. This study explored how pharmacoeconomic models can inform the procurement of TKA devices to improve their value for money. Our study included three phases: i) literature search for data of outcome, cost, and device type in TKA; ii) development of a Markov model predicting costs, QALYs, and net monetary benefit (NMB); iii) simulation of tenders aimed at value-based device procurement. Phases 1 and 2 were managed by selecting a single study as the source of data for our analysis. In Phase 3, each TKA device was associated with its values of NMB, and the tender scores were estimated. Finally, the ranking of each device in the simulated tender was determined. We identified a study published in 2016 as our source of data. Five devices were evaluated. For these devices, QALYs were 7.3952, 7.2939, 7.4952, 7.1919, 7.2930; NMB: £142,005, £140,653, £144,184, £138,040, £140,261; tender scores: 64.53, 42.53, 100, 0, 36.15, respectively. We showed that incorporating the principles of cost-effectiveness into the tendering process is feasible for TKA devices. This can maximize the value for money for these devices.
topic knee arthroplasty
cost-effectiveness
Markov modeling
net monetary benefit
tenders
procurement
url http://www.pagepress.org/journals/index.php/or/article/view/7488
work_keys_str_mv AT andreamessori valuebasedprocurementofprosthesesfortotalkneereplacement
AT sabrinatrippoli valuebasedprocurementofprosthesesfortotalkneereplacement
_version_ 1721487368145338368